Abstract:Objective To investigate association of the paired box 4 (PA X 4) gene rs3824004 (574C>A; R192S) and rs2233580 (575G>A; R192H) polymorphism with obesity and metabolic markers in children and adolescents. Methods A total of 103 obese children were randomly selected, and an average age was (10.82±2.57) years, and body mass index (BMI) was (26.82±4.57) kg/m2. At the same period, 100 normal weight children were selected as the control group, and an average age of (10.60±2.84) years, and BMI was (16.79±2.13) kg/m2. The blood pressure, physical measurements, and blood metabolic parameters were measured and compared. The oral glucose tolerance test (OGTT) and insulin release test were performed in the obesity group. The homeostasis model insulin resistance index (HOMA-IR) and the overall insulin sensitivity index (WBISI) were calculated. PA X 4 rs3824004 and rs2233580 polymorphism were detected by PCR.The differences of allele frequency and genotype frequency of polymorphic loci were analyzed, and the correlation between different genotypes and metabolic indexes was analyzed. Results The height, weight, BMI, systolic blood pressure, diastolic blood pressure, waist circumference, hip circumference, waist to height ratio (WHtR), fasting blood glucose (FPG), total cholesterol (TC), low density lipoprotein (LDL), triacylglycerol (TG), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in the obesity group were significantly higher than those in the control group, and the high density lipoprotein (HDL) was significantly lower than that in the control group (all P<0.05). The frequency of gene distribution was in accordance with the Hard-Weinberg balance. The frequencies of A allele of rs3824004 in obesity and control groups were 4.9% and 5.0%, respectively, and the frequencies of CA genotype were 9.7% and 10.0%, respectively, and there was no significant difference between two groups (P>0.05). The frequency of GA allele of rs2233580 in obesity group was 25.2%, which was significantly higher than that in control group (P<0.05). The BMI and waist in rs2233580 GA genotype were significantly higher than those in GG genotype (all P <0.05). However,logistic regression analysis showed that there was no correlation between PA X 4 rs2233580 genotype and metabolic markers (all P>0.05).There were no significantly differences in HOMA-IR and WBISI among different genotypes of PA X 4 rs2233580 in obesity group(all P>0.05).Conclusions PA X 4 rs2233580 affects children's BMI and waist circumference and may be involved in the development of childhood obesity, but it is not an independent risk factor for obesity in children and adolescents.

Pro12Ala Polymorphism of the PPAR-γ Gene is not Associated with BMI and Energy Metabolism among Healthy Nigerian Males

Association between PPAR-γ2 Pro12Ala polymorphism and obesity: a meta-analysis

The Pro~(12) → Ala Substitution in PPARγ_2 Gene May Be a Protective Factor for the Development of Type 2(diabetes) in Chinese Han Population

Pro12Ala Substitution in the Peroxisome Proliferator-Activated Receptor Gamma (pparγ) Gene and Non-Alcoholic Fatty Liver Disease

Effects of peroxisome proliferator activated receptor-gamma 2 gene Pro12Ala polymorphism on fasting blood lipids: A meta-analysis

Is the rs1801282 (G/C) Polymorphism of PPAR - Gamma Gene Associated with T2DM in Iraqi People?

Association of PA X 4 R192S and R192H polymorphism with obesity in children and adolescents

Study on the Relationship Between Peroxisome Proliferator Activated Receptor-Γ(pparγ) Gene Polymorphism and Obesity, or Abnormal Glucose Metabolism in Adolescents

Association Between the Pro12Ala Polymorphism of PPAR-γ Gene and the Polycystic Ovary Syndrome: A Meta-Analysis of Case–control Studies

[Meta-Analysis of the Association of Pro12Ala Polymorphism of Peroxisome Proliferator Activated Receptor Gamma Gene with Type 2 Diabetes in Chinese Han Population].

Associations of the PPARα and Lipoprotein Lipase Enzyme Gene Polymorphisms with Dyslipidemia in Obese and Non-obese Males

Association Between Peroxisome Proliferator-Activated Receptor-Alpha, Delta, and Gamma Polymorphisms and Risk of Coronary Heart Disease A Case-Control Study and Meta-Analysis

A Val227Ala Substitution in the Peroxisome Proliferator Activated Receptor Alpha (PPAR Alpha) Gene Associated with Non‐alcoholic Fatty Liver Disease and Decreased Waist Circumference and Waist‐to‐hip Ratio

PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis

Evaluation of Leptin Receptor Lys109Arg Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease

Tests of Linkage And/or Association of the LEPR Gene Polymorphisms with Obesity Phenotypes in Caucasian Nuclear Families

The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis

Pparg Gene Pro12ala Variant Contributes to the Development of Non-Alcoholic Fatty Liver in Middle-Aged and Older Chinese Population

The association study between peroxisome proliferator-activated receptor γ2 gene polymorphism and type 2 diabetes mellitus

Meta-analysis on the Effect of the Ala54Thr Polymorphism of the Fatty Acid-Binding Protein 2 Gene on Body Mass Index

A Preliminary Study on the Association of the Peroxisome Proliferator-Activated Receptor-Γ Gene Pro12Ala Polymorphism with the Efficacy of Pioglitazone